Abstract: An optical amplifier and a related device are provided to reduce a nonlinear penalty of a gain medium. The optical amplifier includes a first gain medium, a second gain medium, a first multiplexer/demultiplexer, and a second multiplexer/demultiplexer. The second multiplexer/demultiplexer is configured to output, to the first gain medium in a coupling manner, a first optical signal and first gain clamping light output by the first multiplexer/demultiplexer. The first optical signal is an input optical signal of the optical amplifier, or is an optical signal obtained by amplifying the input optical signal of the optical amplifier. The first gain medium is configured to: amplify the first optical signal, and perform gain clamping on the first optical signal based on the first gain clamping light, to obtain target light. The second gain medium is configured to amplify the target light or the target light amplified through a target gain medium.

Abstract: A photothermal catalytic method for production of hydrogen peroxide without a sacrificial reagent on the basis of a porphyrin-based supermolecule is provided. The method includes the following steps: uniformly mixing a porphyrin-based supermolecule photocatalyst with a concentration of 0.3-1.5 g/L with ultrapure water, conducting irradiation with a visible light for a period of time under stirring at a temperature of 40-80° C. and an O2 flow rate of 50-150 mL/min, and then filtering and concentrating a reaction liquid to obtain an aqueous hydrogen peroxide solution with a high concentration. The method is simple in operation, mild in reaction conditions and high in production of the hydrogen peroxide.

Abstract: The present invention provides anti-PD-L1 antigen binding molecules, including antibodies and the antigen binding fragment thereof, and methods for using the same for treating a variety of diseases, including cancers. The antibodies may be delivered to a subject within a pharmaceutical composition for treatment of a variety of diseases, including various types of cancers. Administration results in an activated immune system that can then target tumor cells within the subject. Additional therapeutic agents, including other pharmaceuticals, may be administered in conjunction with the molecules of the invention to aid the treatment of the subject.

Abstract: A nanocatalyst including single atoms of platinum dispersed on a nanoscale metal oxide, and the nanocatalyst comprises 0.01 wt % to 1 wt % platinum. Preparing the nanocatalyst includes combining a solution comprising a nanoscale metal oxide and a compound containing a Group 10 metal to yield a mixture, aging the mixture for a length of time, filtering the mixture to yield a solid, washing the solid to eliminate water soluble anions, and calcining the solid to yield a nanocatalyst including single atoms or clusters of atoms of the Group 10 metal on the nanoscale metal oxide.

Abstract: A photothermal catalytic method for production of hydrogen peroxide without a sacrificial reagent on the basis of a porphyrin-based supermolecule is provided. The method includes the following steps: uniformly mixing a porphyrin-based supermolecule photocatalyst with a concentration of 0.3-1.5 g/L with ultrapure water, conducting irradiation with a visible light for a period of time under stirring at a temperature of 40-80° C. and an O2 flow rate of 50-150 mL/min, and then filtering and concentrating a reaction liquid to obtain an aqueous hydrogen peroxide solution with a high concentration. According to the new photothermal catalytic method for preparing the hydrogen peroxide provided in the present disclosure, no organic solvent (such as ethanol, isopropanol and benzyl alcohol) is used as a sacrificial reagent, and the method is environmentally friendly and free of pollution.

Abstract: A nanocatalyst including single atoms of platinum dispersed on a nanoscale metal oxide, and the nanocatalyst comprises 0.01 wt % to 1 wt % platinum. Preparing the nanocatalyst includes combining a solution comprising a nanoscale metal oxide and a compound containing a Group 10 metal to yield a mixture, aging the mixture for a length of time, filtering the mixture to yield a solid, washing the solid to eliminate water soluble anions, and calcining the solid to yield a nanocatalyst including single atoms or clusters of atoms of the Group 10 metal on the nanoscale metal oxide.

Abstract: A nanocatalyst including single atoms of platinum dispersed on a nanoscale metal oxide, and the nanocatalyst comprises 0.01 wt % to 1 wt % platinum. Preparing the nanocatalyst includes combining a solution comprising a nanoscale metal oxide and a compound containing a Group 10 metal to yield a mixture, aging the mixture for a length of time, filtering the mixture to yield a solid, washing the solid to eliminate water soluble anions, and calcining the solid to yield a nanocatalyst including single atoms or clusters of atoms of the Group 10 metal on the nanoscale metal oxide.

Abstract: The disclosure provides rabbit monoclonal antibodies against the spike S1 protein of SARS-CoV-2 and uses thereof. The antibody comprises: a VH CDR1 selected from the group consisting of SEQ ID NO: 1-7; a VH CDR2 selected from the group consisting SEQ ID NO: 8-14; a VH CDR3 selected from the group consisting of SEQ ID NO: 15-21; a VL CDR1 selected from the group consisting SEQ IDN NO: 22-28; a VL CDR2 selected from the group consisting of SEQ ID NO: 29-35; and a VL CDR3 selected from the group consisting of SEQ ID NO: 36-42. The antibodies can be used for a rapid test or screening of SARS-CoV-2 infection. The antibodies can also be used for treating SARS-CoV-2 infection.

Abstract: The disclosure provides rabbit monoclonal antibodies against the nucleocapsid protein of SARS-CoV-2 and uses thereof. The antibody comprises: a VH CDR1 selected from the group consisting of SEQ ID NO: 1-7; a VH CDR2 selected from the group consisting SEQ ID NO: 8-14; a VH CDR3 selected from the group consisting of SEQ ID NO: 15-21; a VL CDR1 selected from the group consisting SEQ ID NO: 22-28; a VL CDR2 selected from the group consisting of SEQ ID NO: 29-35; and a VL CDR3 selected from the group consisting of SEQ ID NO: 36-42. The antibodies can be used for a rapid test or screening of SARS-CoV-2 infection and detecting SARS-CoV-2 nucleocapsid protein.

Abstract: Improved ultrasound imaging using coherence estimation of a beamformed signal. Ultrasound imaging using coherence estimation of a beamformed signal as described herein may be performed by applying a plurality of filters to the beamformed signal to generate a plurality of filtered beamformed signals. Normalized cross-correlation may be performed on a plurality of pairs of filtered beamformed signals to determine a coherence coefficient corresponding to each pixel of an ultrasound image, which may be used to construct a coherence estimation ultrasound image.

Abstract: A nanocatalyst including single atoms of platinum dispersed on a nanoscale metal oxide, and the nanocatalyst comprises 0.01 wt % to 1 wt % platinum. Preparing the nanocatalyst includes combining a solution comprising a nanoscale metal oxide and a compound containing a Group 10 metal to yield a mixture, aging the mixture for a length of time, filtering the mixture to yield a solid, washing the solid to eliminate water soluble anions, and calcining the solid to yield a nanocatalyst including single atoms or clusters of atoms of the Group 10 metal on the nanoscale metal oxide.

Abstract: The disclosure provides an anti-human PD-L1 antibody and uses thereof.

Abstract: A method of creating haptic stimulations and anatomical information includes a wearable device including a plurality of transducers that can each generate one or more waves. The method includes activating one or more first transducers of the plurality of transducers based on an instruction received from a remote device. Waves generated by the activated one or more first transducers provide a haptic stimulation. The method further includes activating one or more second transducers of the plurality of transducers. Waves generated by the activated one or more second transducers provide anatomical information of a user of the wearable device when the waves are received by one or more transducers of the plurality of transducers.

Abstract: A method of creating haptic stimulations and anatomical information includes a wearable device including a plurality of transducers that can each generate one or more waves. The method includes activating one or more first transducers of the plurality of transducers based on an instruction received from a remote device. Waves generated by the activated one or more first transducers provide a haptic stimulation. The method further includes activating one or more second transducers of the plurality of transducers. Waves generated by the activated one or more second transducers provide anatomical information of a user of the wearable device when the waves are received by one or more transducers of the plurality of transducers.

Abstract: The present invention discloses a method and a client for producing a small window at the client in a broadband data intelligent service, comprising: pre-setting a first module and a second module; while a user needs to use data service, obtaining, by the first module, the IP address of the client, and sending the IP address and authentication information input by the client to the portal server; upon receiving a past authentication message from the portal server, the first module making the second module to operate; and generating, by the second module, a small window to display the access information of the client and provide the user with operation buttons. Moreover, the present invention also discloses a method a device and a system for generating a user interface for a client terminal in a communication network.

Abstract: The present invention discloses a method and a client for producing a small window at the client in a broadband data intelligent service, comprising: pre-setting a first module and a second module; while a user needs to use data service, obtaining, by the first module, the IP address of the client, and sending the IP address and authentication information input by the client to the portal server; upon receiving a past authentication message from the portal server, the first module making the second module to operate; and generating, by the second module, a small window to display the access information of the client and provide the user with operation buttons. Moreover, the present invention also discloses a method a device and a system for generating a user interface for a client terminal in a communication network.